Thrombotic Thrombocytopenic Purpura Treated with Rituximab Associated with Primary Sjögren's Syndrome and Primary Hypothyroidism.

Therefore, even if the standard treatments, including PE, generate responses initially, rituximab treatment should be considered promptly when the therapeutic effects with the initial treatment worsen and re-exacerbation is observed, such as platelet re-reduction or an increasing trend in ADAMTS13 inhibitor.

also in 63,971 other papers